Grapevine: KKR, JB Pharma, ONGC, Peak XV-backed Capillary, and Pernia in news

By Sreeja Biswas

  • 07 Nov 2024
Premium
Credit: 123RF.com

After failing to reach a deal with private equity firms for the sale of its stake in JB Chemicals & Pharmaceuticals, KKR & Co. is now exploring another option for monetisation, while ONGC is weighing partnership with another state-owned unit for its bid to acquire Ayana Renewable Power, according to ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.